Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 4, 2009, Pages

  Govindarajan, Rajgopal ^a   Leung, George P H ^b   Zhou, Mingyan ^a   Tse, Chung Ming ^b   Wang, Joanne ^a   Unadkat, Jashvant D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti human immunodeficiency virus drugs; Lysosomes; Mitochondrial transport

Indexed keywords

EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 3; FIALURIDINE; GEMCITABINE; RIBAVIRIN; SMALL INTERFERING RNA; STAVUDINE; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN; ANTIBODY; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BACTERIAL PROTEIN; EPITOPE; NUCLEOSIDE TRANSPORTER; PHOTOPROTEIN; SLC29A3 PROTEIN, HUMAN; YELLOW FLUORESCENT PROTEIN, BACTERIA;

ARTICLE; CELL FRACTIONATION; CELL SURFACE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; LIVER CELL; LYSOSOME; MITOCHONDRIAL TOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL LINE; FEMALE; LIVER MITOCHONDRION; METABOLISM; PLACENTA; TISSUE CULTURE TECHNIQUE;

ANTIBODIES; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BACTERIAL PROTEINS; CELL LINE; EPITOPES; FEMALE; GENE SILENCING; HEPATOCYTES; HUMANS; LUMINESCENT PROTEINS; MITOCHONDRIA, LIVER; NUCLEOSIDE TRANSPORT PROTEINS; PLACENTA; RNA, SMALL INTERFERING; TISSUE CULTURE TECHNIQUES;

EID: 66149097607     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90672.2008     Document Type: Article

References (39)

1. Addanki S, Cahill D, Sotos JF. Determination of intramitochondrial pH and intramitochondrial-extramitochondrial pH gradient of isolated heart mitochondria by the use of 5,5-dimethyl-2,4-oxazolidinedione. J Biol Chem 243: 2337-2348, 1968.
2. Addanki S, Cahill D, Sotos JF. Reliability of the quantitation of intra-mitochondrial pH and pH gradient of heart mitochondria. Anal Biochem 25: 17-29, 1968.
3. Arner ES, Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol Ther 67: 155-186, 1995.
4. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. The equilibrative nucleoside transporter family, SLC29. Pflügers Arch 447: 735-743, 2004.
5. Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, Ritzel MW, Cass CE, Young JD. Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 280: 15880-15887, 2005.
6. Barnes K, Dobrzynski H, Foppolo S, Beal PR, Ismat F, Scullion ER, Sun L, Tellez J, Ritzel MW, Claycomb WC, Cass CE, Young JD, Billeter-Clark R, Boyett MR, Baldwin SA. Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ Res 99: 510-519, 2006.
7. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 356: 1423-1430, 2000.
8. Chang C, Swaan PW, Ngo LY, Lum PY, Patil SD, Unadkat JD. Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1. Mol Pharmacol 65: 558-570, 2004.
9. Divi RL, Leonard SL, Kuo MM, Nagashima K, Thamire C, St Claire MC, Wade NA, Walker VE, Poirier MC. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Environ Mol Mutagen 48: 201-209, 2007.
10. Dragovic G, Jevtovic D. Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV/AIDS patients. Antivir Chem Chemother 14: 281-284, 2003.
11. Engel K, Zhou M, Wang J. Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279: 50042-50049, 2004.
12. Govindarajan R, Bakken AH, Hudkins KL, Lai Y, Casado FJ, Pastor-Anglada M, Tse CM, Hayashi J, Unadkat JD. In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta. Am J Physiol Regul Integr Comp Physiol 293: R1809-R1822, 2007.
13. Govindarajan R, Endres CJ, Whittington D, Lecluyse E, Pastor-Anglada M, Tse CM, Unadkat JD. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes. Am J Physiol Gastrointest Liver Physiol 295: G570-G580, 2008.
14. Hainers TH, Dencher NA. Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett 528: 35-39, 2002.
15. Honkoop P, Scholte HR, de Man RA, Schalm SW. Mitochondrial injury: lessons from the fialuridine trial. Drug Saf 17: 1-7, 1997.
16. Hyde RJ, Cass CE, Young JD, Baldwin SA. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18: 53-63, 2001.
17. Igamberdiev AU, Kleczkowski LA. Equilibration of adenylates in the mitochondrial intermembrane space maintains respiration and regulates cytosolic metabolism. J Exp Bot 57: 2133-2141, 2006.
18. John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ, Mallal SA. Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS 15: 717-723, 2001.
19. Khalifat N, Puff N, Bonneau S, Fournier J, Angelova MI. Membrane deformation under local pH gradient: mimicking mitochondrial cristae dynamics. Biophys J 95: 4924-4933, 2008.
20. Kohler JJ, Lewis W. A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen 48: 166-172, 2007.
21. Lai Y, Tse CM, Unadkat JD. Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. J Biol Chem 279: 4490-4497, 2004.
22. Lee EW, Lai Y, Zhang H, Unadkat JD. Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine. J Biol Chem 281: 16700-16706, 2006.
23. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med 1: 417-422, 1995.
24. Lewis W. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy. Antivir Ther 10, Suppl 2: M13-M27, 2005.
25. Lum PY, Ngo LY, Bakken AH, Unadkat JD. Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profiles. Cancer Chemother Pharmacol 45: 273-278, 2000.
26. McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Pruett T, Stokka JL, Straus SE, Hoofnagle JH. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 333: 1099-1105, 1995.
27. Molho-Pessach V, Lerer I, Abeliovich D, Agha Z, Abu Libdeh A, Broshtilova V, Elpeleg O, Zlotogorski A. The H syndrome is caused by mutations in the nucleoside transporter hENT3. Am J Hum Genet 83: 529-534, 2008.
28. Moore AL, Rich PR. Organization of the respiratory chain and oxidative phosphorylation. In: Encyclopedia of Plant Physiology, Vol. 18. Higher Plant Cell Respiration, edited by Douce R, Day DA. Berlin: Springer, 1985, p. 134-172.
29. Nakamura Y, Suzuki H, Sakaguchi M, Mihara K. Targeting and assembly of rat mitochondrial translocase of outer membrane 22 (TOM22) into the TOM complex. J Biol Chem 279: 21223-21232, 2004.
30. Nantel A, Huber M, Thomas DY. Localization of endogenous Grb10 to the mitochondria and its interaction with the mitochondrial-associated Raf-1 pool. J Biol Chem 274: 35719-35724, 1999.
31. Neve EP, Ingelman-Sundberg M. Identification and characterization of a mitochondrial targeting signal in rat cytochrome P450 2E1 (CYP2E1). J Biol Chem 276: 11317-11322, 2001.
32. Pfanner N, Geissler A. Versatility of the mitochondrial protein import machinery. Nat Rev Mol Cell Biol 2: 339-349, 2001.
33. Pisoni RL, Thoene JG. Detection and characterization of a nucleoside transport system in human fibroblast lysosomes. J Biol Chem 264: 4850-4856, 1989.
34. Pujol C, Marechal-Drouard L, Duchene AM. How can organellar protein N-terminal sequences be dual targeting signals? In silico analysis and mutagenesis approach. J Mol Biol 369: 356-367, 2007.
35. Robin MA, Anandatheerthavarada HK, Biswas G, Sepuri NB, Gordon DM, Pain D, Avadhani NG. Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation. J Biol Chem 277: 40583-40593, 2002.
36. Shayeghi M, Akerman R, Jarvis SM. Nucleobase transport inopossum kidney epithelial cells and Xenopus laevis oocytes: the characterisation, structure-activity relationship of uracil analogues and oocyte expression studies of sodium-dependent and -independent hypoxanthine uptake. Biochim Biophys Acta 1416: 109-118, 1999.
37. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99: 4465- 4470, 2002.
38. +-nucleoside transporter. Mol Pharmacol 55: 234-240, 1999.
39. Yao SY, Ng AM, Sundaram M, Cass CE, Baldwin SA, Young JD. Transport of antiviral 3′-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes. Mol Membr Biol 18: 161-167, 2001.